HKEX: 2315 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Yield per half year: +10.65%
Sector: Healthcare

Current price
6.3 HK$
Average price
8.83 HK$ +40.2%

Price based on EPS
10.65 HK$ +69.02%
Discount price Net Income
7.02 HK$ +11.37%
10/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 10.65 HK$
Current price = 6.3 HK$ (difference = +69.02%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 61.04 HK$
Current price = 6.3 HK$ (difference = +868.91%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -1.2 HK$
Current price = 6.3 HK$ (difference = -119.02%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription